Prof. Schulz had established and led an independent research group within the Department of Pathophysiology, University of Essen, Medical School, and since January 2011 he has been appointed as Chairman of Physiology at the Justus-Liebig University Giessen. He has achieved international recognition for his research on myocardial ischemia/reperfusion injury (IRI) and protection from it. His research group uses a translational approach from subcellular particles towards large animal model to define new targets involved in IRI and investigate novel treatment strategies for protecting the heart. He published more than 300 peer-reviewed articles (h-index 79) with the total number of citations over 22000. He serve on the Editorial Board of several prestigious cardiovascular journals and it is a prestigious member of European Society of Cardiology.